Evidence map›Paper›PMID 32973453›Full record

ArticleFrontiers in cellular neuroscience2020

Expression and Function of GABA Receptors in Myelinating Cells.

Mari Paz Serrano-Regal, Laura Bayón-Cordero, Rainald Pablo Ordaz, Edith Garay, Agenor Limon, Rogelio O Arellano, Carlos Matute, María Victoria Sánchez-Gómez

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Central Dysmyelination in SSADH-Deficient Humans and Mice.Annals of clinical and translational neurology · 2025
    Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Heliyon · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Regulation of the E/I-balance by the neural matrisome.Frontiers in molecular neuroscience · 2023
    Review
  20. Transcriptional and bioinformatic analysis of GABAFrontiers in molecular neuroscience · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Mari Paz Serrano-RegalLaboratory of Neurobiology, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Laura Bayón-CorderoLaboratory of Neurobiology, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Rainald Pablo OrdazLaboratorio de Neurofisiología Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Edith GarayLaboratorio de Neurofisiología Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Agenor LimonDepartment of Neurology, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, United States.
Rogelio O ArellanoLaboratorio de Neurofisiología Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
Carlos MatuteLaboratory of Neurobiology, Achucarro Basque Center for Neuroscience, Leioa, Spain.
María Victoria Sánchez-GómezLaboratory of Neurobiology, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Universidad Nacional Autónoma de México · MXUniversity of the Basque Country · ESAchucarro Basque Center for Neuroscience · ESThe University of Texas Medical Branch at Galveston · US

Funding

Synaptic Imbalance in Mild Cognitive Impairment and Alzheimer's DiseaseR21AG053740 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAUTERBORN, JULIE C, LIMON, AGENOR · 2016 to 2017
$425k
Multidimensional Analysis of Synaptic Dysfunction in SchizophreniaR21MH113177 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI LIMON, AGENOR, VAWTER, MARQUIS PHILIP · 2017 to 2018
$425k
NIA NIH HHS R21 AG053740NIMH NIH HHS R21 MH113177
6 · The paper itself

Abstract

Myelin facilitates the fast transmission of nerve impulses and provides metabolic support to axons. Differentiation of oligodendrocyte progenitor cells (OPCs) and Schwann cell (SC) precursors is critical for myelination during development and myelin repair in demyelinating disorders. Myelination is tightly controlled by neuron-glia communication and requires the participation of a wide repertoire of signals, including neurotransmitters such as glutamate, ATP, adenosine, or γ-aminobutyric acid (GABA). GABA is the main inhibitory neurotransmitter in the central nervous system (CNS) and it is also present in the peripheral nervous system (PNS). The composition and function of GABA receptors (GABARs) are well studied in neurons, while their nature and role in glial cells are still incipient. Recent studies demonstrate that GABA-mediated signaling mechanisms play relevant roles in OPC and SC precursor development and function, and stand out the implication of GABARs in oligodendrocyte (OL) and SC maturation and myelination. In this review, we highlight the evidence supporting the novel role of GABA with an emphasis on the molecular identity of the receptors expressed in these glial cells and the possible signaling pathways involved in their actions. GABAergic signaling in myelinating cells may have potential implications for developing novel reparative therapies in demyelinating diseases.

Indexed as

differentiationGABAGABA receptormyelinationoligodendrocyteSchwann cell

Identifiers

PMID32973453
PMCPMC7472887
OpenAlexW3081316248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.